Search Results

Protective effects of dietary fish‐oil supplementation on skin inflammatory and oxidative stress biomarkers induced by fine particulate air pollution: a pilot randomized, double‐blind, placebo‐controlled trial*.

• Authors : Lin, Z.; Niu, Y.; Jiang, Y.

Subjects: AIR pollution; DIETARY supplements; OXIDATIVE stressSHANGHAI (China)

• Source: British Journal of Dermatology; Feb2021, Vol. 184 Issue 2, p261-269, 9p

Record details

The direct cellular target of topically applied pimecrolimus may not be infiltrating lymphocytes.

• Authors : Fiorentino, D. F.; Chen, R. O.; Stewart, D. B.

Subjects: LYMPHOCYTES; ATOPIC dermatitis treatment; IMMUNOSUPPRESSION

• Source: British Journal of Dermatology; May2011, Vol. 164 Issue 5, p996-1003, 8p

Record details

Nonlinear spectral imaging of human hypertrophic scar based on two-photon excited fluorescence and second-harmonic generation.

• Authors : Chen, G.; Chen, J.; Zhuo, S.

Subjects: SECOND harmonic generation; NONLINEAR optics; COLLAGEN

• Source: British Journal of Dermatology; Jul2009, Vol. 161 Issue 1, p48-55, 8p, 12 Color Photographs, 3 Graphs

Record details

Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.

• Authors : Wang, T. C.; Jee, S. H.; Tsai, T. F.

Subjects: BREAST cancer; PROTEIN-tyrosine kinases; IMMUNOCYTOCHEMISTRY

• Source: British Journal of Dermatology; Aug2005, Vol. 153 Issue 2, p282-289, 8p

Record details

Wound healing effects of porcine placental extracts on rats with thermal injury.

• Authors : Wu, C-H.; Chang, G-Y.; Chang, W-C.

Subjects: PLACENTAL extracts; WOUND healing

• Source: British Journal of Dermatology; Feb2003, Vol. 148 Issue 2, p236-245, 10p

Record details

A woman with iatrogenic androgenetic alopecia responding to finasteride.

• Authors : Hong, J. B.; Chiu, H. C.; Chan, J. Y.

Subjects: LETTERS to the editor; FINASTERIDE; THERAPEUTICS

• Source: British Journal of Dermatology; Apr2007, Vol. 156 Issue 4, p754-755, 2p, 1 Color Photograph

Record details

A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis.

• Authors : Cai L; Department of Dermatology, Peking University People's Hospital, Beijing, China.; Jiang C

• Source: The British journal of dermatology [Br J Dermatol] 2024 Feb 15. Date of Electronic Publication: 2024 Feb 15.Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details